Literature DB >> 10915604

Human monoclonal antibody 98-6 reacts with the fusogenic form of gp41.

Y Taniguchi1, S Zolla-Pazner, Y Xu, X Zhang, S Takeda, T Hattori.   

Abstract

A mixture of two peptides from gp41 (N36 and C34) forms an alpha-helical structure that is thought to represent the fusogenic form of gp41. A human anti-gp41 monoclonal antibody (mAb 98-6), generated from the cells of an infected individual, reacted poorly with C34, but binding was strongly enhanced when N36 was added, indicating that the mAb reacts with a conformational epitope present in the fusogenic structure formed by the interaction of peptides N36 and C34. The epitope recognized by mAb 98-6 was found in lysates of virions on oligomeric forms of gp41 (dimers, trimers, and tetramers). On infected cells, the epitope was present as oligomers of gp41, as monomers of gp41, and as part of the envelope polyprotein gp160, obtained after biotinylation of intact cells, which were then lysed and immunoprecipitated with various mAbs. In lysates of infected cells, the epitope was present as part of both monomeric gp41 and gp160. These studies demonstrate that infected humans can respond to the fusogenic form of gp41 and that the anti-gp41 mAb studied here recognizes a conformational epitope formed by the interaction of two regions of gp41, which forms an alpha-helical bundle. This epitope is found on several forms of gp41 as it occurs in virions, on the surface of infected cells, and in infected cells. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10915604     DOI: 10.1006/viro.2000.0436

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  6 in total

1.  Antigenic properties of the human immunodeficiency virus transmembrane glycoprotein during cell-cell fusion.

Authors:  Catherine M Finnegan; Werner Berg; George K Lewis; Anthony L DeVico
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

2.  Nonneutralizing HIV-1 gp41 envelope cluster II human monoclonal antibodies show polyreactivity for binding to phospholipids and protein autoantigens.

Authors:  S Moses Dennison; Kara Anasti; Richard M Scearce; Laura Sutherland; Robert Parks; Shi-Mao Xia; Hua-Xin Liao; Miroslaw K Gorny; Susan Zolla-Pazner; Barton F Haynes; S Munir Alam
Journal:  J Virol       Date:  2010-11-24       Impact factor: 5.103

3.  Stabilization of the soluble, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1.

Authors:  Rogier W Sanders; Mika Vesanen; Norbert Schuelke; Aditi Master; Linnea Schiffner; Roopa Kalyanaraman; Maciej Paluch; Ben Berkhout; Paul J Maddon; William C Olson; Min Lu; John P Moore
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

4.  Cryo-ET of Env on intact HIV virions reveals structural variation and positioning on the Gag lattice.

Authors:  Vidya Mangala Prasad; Daniel P Leaman; Klaus N Lovendahl; Jacob T Croft; Mark A Benhaim; Edgar A Hodge; Michael B Zwick; Kelly K Lee
Journal:  Cell       Date:  2022-02-04       Impact factor: 41.582

5.  Neutralizing antibody responses in macaques induced by human immunodeficiency virus type 1 monovalent or trivalent envelope glycoproteins.

Authors:  Gerald V Quinnan; Pengfei Zhang; Ming Dong; Hong Chen; Yan-Ru Feng; Mark Lewis; Christopher C Broder
Journal:  PLoS One       Date:  2013-03-22       Impact factor: 3.240

6.  Assessment of antibody responses against gp41 in HIV-1-infected patients using soluble gp41 fusion proteins and peptides derived from M group consensus envelope.

Authors:  Adam Penn-Nicholson; Dong P Han; Soon J Kim; Hanna Park; Rais Ansari; David C Montefiori; Michael W Cho
Journal:  Virology       Date:  2007-12-19       Impact factor: 3.616

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.